Is Tekla Life Stock a Good Investment?
Tekla Life Investment Advice | HQL |
- Examine Tekla Life's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Tekla Life's leadership team and their track record. Good management can help Tekla Life navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Asset Management & Custody Banks space and any emerging trends that could impact Tekla Life's business and its evolving consumer preferences.
- Compare Tekla Life's performance and market position to its competitors. Analyze how Tekla Life is positioned in terms of product offerings, innovation, and market share.
- Check if Tekla Life pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Tekla Life's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Tekla Life Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Tekla Life Sciences is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Tekla Life Stock
Researching Tekla Life's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 35.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Tekla Life Sciences last dividend was issued on the 21st of November 2024.
To determine if Tekla Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Tekla Life's research are outlined below:
| Tekla Life Sciences generated a negative expected return over the last 90 days | |
| Tekla Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Tekla Life Sciences has about 292.4 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Latest headline from seekingalpha.com: abrdn Life Sciences Investors declares 0.50 dividend |
Tekla Life Quarterly Cash And Short Term Investments |
|
Tekla Life's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 386.46 M.Market Cap |
|
Tekla Life's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.04 | |
| Return On Capital Employed | (0.01) | (0.02) | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 0.05 | 0.04 |
Determining Tekla Life's profitability involves analyzing its financial statements and using various financial metrics to determine if Tekla Life is a good buy. For example, gross profit margin measures Tekla Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Tekla Life's profitability and make more informed investment decisions.
Evaluate Tekla Life's management efficiency
The value of Return On Tangible Assets is estimated to slide to 0.04. The value of Return On Capital Employed is expected to slide to -0.02. At this time, Tekla Life's Total Current Assets are quite stable compared to the past year. Asset Turnover is expected to rise to 0.06 this year, although the value of Total Assets will most likely fall to about 335.6 M. Tekla Life's management efficiency ratios could be used to measure how well Tekla Life manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 17.25 | 16.79 | |
| Tangible Book Value Per Share | 17.25 | 16.79 | |
| Enterprise Value Over EBITDA | 13.45 | 14.12 | |
| Price Book Value Ratio | 0.96 | 0.92 | |
| Enterprise Value Multiple | 13.45 | 14.12 | |
| Price Fair Value | 0.96 | 0.92 | |
| Enterprise Value | 300.7 M | 233 M |
At Tekla Life Sciences, management's focus on innovation and efficiency has led to impressive financial results. We assess these factors to determine the stock's attractiveness to investors.
Dividend Yield 0.1437 | Forward Dividend Yield 0.1437 | Forward Dividend Rate 2 | Beta 0.705 |
Basic technical analysis of Tekla Stock
As of the 28th of November, Tekla Life has the Variance of 1.4, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,275). Tekla Life technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Tekla Life Sciences standard deviation and value at risk to decide if Tekla Life is priced more or less accurately, providing market reflects its prevalent price of 14.13 per share. Given that Tekla Life Sciences has information ratio of (0.15), we advise you to double-check Tekla Life Sciences's current market performance to make sure the company can sustain itself at a future point.Tekla Life's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tekla Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tekla Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tekla Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tekla Life's Outstanding Corporate Bonds
Tekla Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tekla Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tekla bonds can be classified according to their maturity, which is the date when Tekla Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Tekla Life's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Tekla Life's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 0.837 | |||
| Coefficient Of Variation | (2,275) | |||
| Standard Deviation | 1.18 | |||
| Variance | 1.4 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 6.65 | |||
| Value At Risk | (1.95) | |||
| Potential Upside | 1.51 | |||
| Skewness | (0.88) | |||
| Kurtosis | 4.02 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 0.837 | |||
| Coefficient Of Variation | (2,275) | |||
| Standard Deviation | 1.18 | |||
| Variance | 1.4 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 6.65 | |||
| Value At Risk | (1.95) | |||
| Potential Upside | 1.51 | |||
| Skewness | (0.88) | |||
| Kurtosis | 4.02 |
Consider Tekla Life's intraday indicators
Tekla Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tekla Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Tekla Life Corporate Filings
| 27th of November 2024 Other Reports | ViewVerify | |
| 3rd of September 2024 Other Reports | ViewVerify | |
F4 | 27th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 15th of August 2024 Other Reports | ViewVerify |
Tekla Stock media impact
Far too much social signal, news, headlines, and media speculation about Tekla Life that are available to investors today. That information is available publicly through Tekla media outlets and privately through word of mouth or via Tekla internal channels. However, regardless of the origin, that massive amount of Tekla data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tekla Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tekla Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tekla Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tekla Life alpha.
Tekla Life Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Tekla Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Tekla Life Corporate Management
| Thomas Kent | Independent Trustee | Profile | |
| William Reardon | Independent Trustee | Profile | |
| Elizabeth Nabel | Independent Trustee | Profile | |
| Laura Woodward | Chief Compliance Officer, Treasurer, Secretary | Profile | |
| Peter Branner | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Dividend Share 1.3 | Earnings Share 1.34 | Revenue Per Share 0.134 | Quarterly Revenue Growth 0.07 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Tekla Life's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.